GO
Loading...

Bayer AG

More

  • Europe shares close flat; Bayer up 3%     Thursday, 27 Feb 2014 | 7:00 PM ET

    European stocks closed flat on Friday, boosted by economic data from the U.S.

  • Bayer bids $2.4 billion for Norway's Algeta Tuesday, 26 Nov 2013 | 2:47 AM ET

    German pharmaceutical group Bayer offered to buy Norway's Algeta for $2.4 billion, Algeta said on Tuesday.

  • Oh, baby! Confusion over free birth control Wednesday, 20 Nov 2013 | 11:07 AM ET
    Contraceptive pills.

    A majority of women are unaware birth control is available for free from health insurance plans under Obamacare, although that right faces court challenges.

  • These biotech names are ripe for takeover: Cramer Tuesday, 27 Aug 2013 | 7:19 PM ET

    We could be witnessing the beginning of a merger wave in biotech, Jim Cramer said Tuesday.

  • Amgen to buy Onyx for more than $10 billion Monday, 26 Aug 2013 | 7:51 AM ET

    Amgen has struck a $10 billion-plus deal to buy Onyx Pharmaceuticals, ending a two-month-long auction for the cancer drugmaker.

  • Bayer CEO: Environment becoming more challenging     Wednesday, 31 Jul 2013 | 5:00 AM ET

    Marijn Dekkers, CEO of drug and chemicals company Bayer, tells CNBC that falling earnings in the material sciences division may make it harder to achieve its earnings goals for the year.

  • China blocks Glaxo finance head from leaving Wednesday, 17 Jul 2013 | 11:31 AM ET

    China is preventing a GlaxoSmithKline executive from leaving the country as police accuse the British drugmaker of bribing officials and doctors, the drugmaker says.

  • Dow Chemical to Pay $1.2 Billion in Price-Fixing Case Thursday, 16 May 2013 | 9:49 AM ET

    A federal judge in Kansas City, Kansas, ordered Dow Chemical Co on Wednesday to pay $1.2 billion in a price-fixing case involving chemicals used to make foam products in cars.

  • Europe Shares Close Higher on Italy Hopes Monday, 29 Apr 2013 | 12:01 PM ET

    European shares closed higher on Monday after Italy's new Prime Minister announced his reform plans in his maiden speech to parliament.

  • Germany's Bayer has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider.

  • Bayer CEO: Agriculture Will Drive Profits     Thursday, 25 Apr 2013 | 6:05 AM ET

    Marijn Dekkers, CEO of Bayer, says the positive outlook for 2013 is driven by strong projected strong growth in Healthcare and Crop Sciences and explains how the company is heavily investing in its growth.

  • What Now for Western Drugmakers in India? Tuesday, 2 Apr 2013 | 7:53 PM ET

    Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country with a market potential as large as India's.

  • Bayer CEO: Confident of Meeting Tough Targets     Thursday, 28 Feb 2013 | 6:30 AM ET

    Marijn Dekkers, CEO of Bayer, tells CNBC why the company's development of new drugs make him confident of reaching targets set of 2.5 billion euros in drug sales.

  • Syngenta Upbeat for Spring Planting Season Wednesday, 6 Feb 2013 | 2:20 AM ET

    Syngenta, the world's largest agrochemicals company, said it was confident ahead of the upcoming planting season and will hike its dividend 19 percent after it posted a full-year net profit that beat expectations.

  • Europe Stocks Close Higher; DAX at Multi-Year Highs Friday, 25 Jan 2013 | 11:40 AM ET

    Weak GDP data for the U.K. wasn't enough to stop European shares rising on Friday as Germany's DAX Index reached a level not seen since January 2008 after business climate data was released.

  • Bayer CEO On Innovation vs. Affordable Drugs     Thursday, 24 Jan 2013 | 4:10 AM ET

    Marijn Dekkers, CEO of Bayer, talks to CNBC about the outlook for the pharmaceutical industry

  • Drug Pipelines Begin to Fill For Big Pharma Sunday, 13 Jan 2013 | 4:30 PM ET

    The big U.S. and European drug companies are dealing with their own 'cliff' as blockbuster drugs lose their patent protection. But they are turning back to research and development to fill the gap.

  • Bayer Has Promising Product Pipeline: CEO     Wednesday, 14 Nov 2012 | 11:24 AM ET

    Marijn Dekkers, CEO of Bayer, explains to CNBC that while Bayer has felt increased pressure on drug pricing from governments, its success in research and development has the company positioned for success.

  • Bayer CEO Speaks on $1.2 Billion Deal     Tuesday, 30 Oct 2012 | 12:30 PM ET

    Bayer CEO Marijn Dekkers says the firm's $1.2 billion purchase of Schiff Nutrition will help Bayer build its position in consumer healthcare.

  • RESEARCH ALERT-Cheuvreux cuts Bayer to outperform Friday, 12 Oct 2012 | 4:35 AM ET

    *Cheuvreux cuts Bayer to outperform from selected list. Reuters Station users, click. 1568. Reuters Station users, click. 4899.